Publications by authors named "Rolf Eichenauer"

Claim this Profile
[
[Update from d-uo: what can healthcare research contribute to renal cell carcinoma?].
Manfred Johannsen, Rolf Eichenauer, Jörg Klier, Frank König, Robert Schönfelder

Urologie· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The cancer registry notification seen from the perspective of the German Society of Uro-Oncologists (d-uo)].
Christian Doehn, Manfred Johannsen, Rolf Eichenauer, Jörg Klier, Frank König

Aktuelle Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Real-world data on prostate cancer: the VERSUS trial by d-uo].
Jörg Klier, Frank König, Manfred Johannsen, Rolf Eichenauer, Robert Schönfelder

Aktuelle Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[National Registries for Urothelial Cancer (UroNAT) and Prostate Cancer (ProNAT) by d-uo].
Manfred Johannsen, Jörg Klier, Frank König, Robert Schönfelder, Christian Doehn, Rolf Eichenauer

Aktuelle Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retrospective practice-related care research study on therapy of mCPRC with radium-223 dichloride].
Charlotte Jores, Frank König, Eva Hellmis, Christina Grund, Jörg Klier, Rolf Eichenauer

Aktuelle Urol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retrospective practice-related care research study on therapy of mCPRC with radium-223 dichloride].
Charlotte Jores, Frank König, Eva Hellmis, Christina Grund, Jörg Klier, Rolf Eichenauer

Aktuelle Urol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Osteoprotection in patients with non-metastatic hormone-sensitive prostate cancer (mHSPC) receiving androgen-deprivation therapy (ADT): Real-world data from Germany, presented by d-uo].
Jörg Klier, Frank König, Robert Schönfelder, Rolf Eichenauer, Manfred Johannsen

Aktuelle Urol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Osteoprotection in patients with bone metastatic castration-resistant prostate cancer (mCRPC): real-world data from Germany, presented by d-uo].
Christian Doehn, Jörg Klier, Manfred Johannsen, Rolf Eichenauer, Robert Schönfelder

Aktuelle Urol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CARD study: relevance for the treatment of advanced prostate cancer].
Axel S Merseburger, Andreas Bannowsky, Klaus Becker, Carsten Bokemeyer, Rolf Eichenauer

Aktuelle Urol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Advanced prostate cancer: sequence of androgen receptor-targeted substances and chemotherapy determines long-term survival].
Christian Wülfing, Peter J Goebell, Rolf Eichenauer, Carsten Lange, Stefan Machtens

Urologe A· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degarelix therapy for prostate cancer in a real-world setting: experience from the German IQUO (Association for Uro-Oncological Quality Assurance) Firmagon® registry.
Götz Geiges, Thomas Harms, Gerald Rodemer, Ralf Eckert, Frank König, Rolf Eichenauer

BMC Urol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis